Heart failure & cardiomyopathies
The Icelandic Heart Failure Registry—A Nationwide Assessment Tool for Heart Failure (HF) Care and Intervention in HF Treatment
Authors' conclusion
HF is a heterogenous disease with numerous underlying factors. HF management differs among HF phenotypes. A registry can serve as an unbiased indicator of care quality and has the potential to be studied in the future to assess the long-term effects of HF treatment.
Study context
- Population
- Patients admitted for HF to the Department of Cardiology, Landspítali - The National University Hospital of Iceland, 2020–2022
- Participants
- 1,890 patients · 2,384 admissions
Methodological detailsnationwide HF registry, single-centre, prospective registry, Created autumn 2019, operating since 1 January 2020; based on SwedeHF
- Nationwide HF registry
- Single-centre
- Prospective registry
- Created autumn 2019, operating since 1 January 2020; based on SwedeHF
Main finding
As reported in the abstract
Registry enrolment 2020–2022 · 3 years
Patients admitted
1890
Total admissions (incl. readmissions)
2384
Variables in Icelandic Heart Failure Registry (IHFR) 2023 edition
327
Observational data: associations, not effects.
Original publication
The Icelandic Heart Failure Registry—A Nationwide Assessment Tool for HF Care and Intervention in HF Treatment. ESC Heart Fail. Published 6 August 2024. doi:10.
Summarised from the published abstract; every number is checked against it